Taysha Gene Therapies, Inc. (TSHA)
Drugs • Health Care
Percentage
Change
| Mar 21 | Mar 22 | Mar 23 | Mar 24 | Feb 25 | Mar 26 | |
|---|---|---|---|---|---|---|
Net Income to Common | -89 | -109 | ||||
Net Income | -89 | -109 | ||||
Profit | -89 | -109 | ||||
Net Income Continuing | -89 | -109 | ||||
Pretax Income | -89 | -109 | ||||
Total Non-operating Income | 2 | 2 | ||||
Operating Income | -91 | -110 | ||||
Total Revenue | 8 | 10 | ||||
Total Costs and Expenses | -100 | -120 | ||||
Operating Expenses | -100 | -120 | ||||
Impairment Expense | -5 | 0 | ||||
Research and Development Expenses | -66 | -86 | ||||
Selling, General & Administrative Expenses | -29 | -34 |